Study suggests convalescent plasma may be safe COVID-19 treatment

In a small study of 14 infants and children, convalescent plasma from patients who recovered from COVID-19 infection provided expected antibody levels and raised no safety concerns

Study suggests convalescent plasma may be safe COVID-19 treatment for high risk children

Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma - eClinicalMedicine

NIH clinical trial explores use of convalescent plasma in at-risk outpatients with early COVID-19

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Convalescent Plasma for COVID-19: What Is It and How Can it Help?

Luminis Health Anne Arundel Medical Center Participates in National Study That Finds Convalescent Plasma Can Be Effective as Early Covid-19 Therapy

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

Convalescent plasma to deliver therapeutic antibodies against COVID-19: Trends in Molecular Medicine

Study confirms safety of COVID-19 convalescent plasma therapy

Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis

Convalescent Plasma Is Safe to Treat Covid-19, National Study Shows - WSJ

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

Trial of COVID-19 blood plasma finds no benefit in severely ill patients

Johns Hopkins-Led Study Finds Convalescent Plasma Can Be Effective Early COVID-19 Therapy, Johns Hopkins